Bettina Kulle Andreassen

1.5k total citations
52 papers, 625 citations indexed

About

Bettina Kulle Andreassen is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Bettina Kulle Andreassen has authored 52 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 16 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Bettina Kulle Andreassen's work include Bladder and Urothelial Cancer Treatments (15 papers), Urinary and Genital Oncology Studies (10 papers) and Epigenetics and DNA Methylation (6 papers). Bettina Kulle Andreassen is often cited by papers focused on Bladder and Urothelial Cancer Treatments (15 papers), Urinary and Genital Oncology Studies (10 papers) and Epigenetics and DNA Methylation (6 papers). Bettina Kulle Andreassen collaborates with scholars based in Norway, United States and Australia. Bettina Kulle Andreassen's co-authors include Erik Skaaheim Haug, Tom K. Grimsrud, Christian M. Page, Randi E. Gislefoss, Edoardo Botteri, Jo S Stenehjem, Hanne F. Harbo, Ole A. Andreassen, Trude Eid Robsahm and Sophie D. Fosså and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Bettina Kulle Andreassen

48 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bettina Kulle Andreassen Norway 14 242 158 112 112 74 52 625
A. Eisenhardt Germany 16 257 1.1× 163 1.0× 139 1.2× 67 0.6× 103 1.4× 48 729
Katarzyna Ziemnicka Poland 20 218 0.9× 159 1.0× 168 1.5× 137 1.2× 49 0.7× 89 972
Craig C. Teerlink United States 16 167 0.7× 343 2.2× 98 0.9× 164 1.5× 68 0.9× 51 832
Michaela Onstad United States 10 158 0.7× 90 0.6× 304 2.7× 83 0.7× 177 2.4× 24 736
Claire Briet France 17 270 1.1× 332 2.1× 126 1.1× 137 1.2× 212 2.9× 53 1.2k
Meng Huang China 15 200 0.8× 79 0.5× 183 1.6× 127 1.1× 180 2.4× 49 640
A. O’Meara Ireland 13 189 0.8× 52 0.3× 105 0.9× 80 0.7× 49 0.7× 20 872
Yumiko Okubo Japan 10 336 1.4× 77 0.5× 82 0.7× 135 1.2× 93 1.3× 27 791
Tony Huynh Australia 14 252 1.0× 137 0.9× 97 0.9× 184 1.6× 33 0.4× 42 608
Joon Ho Song South Korea 10 174 0.7× 47 0.3× 133 1.2× 223 2.0× 82 1.1× 38 599

Countries citing papers authored by Bettina Kulle Andreassen

Since Specialization
Citations

This map shows the geographic impact of Bettina Kulle Andreassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina Kulle Andreassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina Kulle Andreassen more than expected).

Fields of papers citing papers by Bettina Kulle Andreassen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bettina Kulle Andreassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina Kulle Andreassen. The network helps show where Bettina Kulle Andreassen may publish in the future.

Co-authorship network of co-authors of Bettina Kulle Andreassen

This figure shows the co-authorship network connecting the top 25 collaborators of Bettina Kulle Andreassen. A scholar is included among the top collaborators of Bettina Kulle Andreassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bettina Kulle Andreassen. Bettina Kulle Andreassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Botteri, Edoardo, Fabio Conforti, Vincenzo Bagnardi, et al.. (2025). Aprepitant use during chemotherapy and association with survival in women with early breast cancer. JNCI Journal of the National Cancer Institute. 117(11). 2249–2258. 2 indexed citations
2.
Klingen, Tor Audun, et al.. (2025). Detection and agreement of blood- and lymph vessel invasion assessed by immunohistochemistry in matched TURBT and radical cystectomy specimens. Pathology - Research and Practice. 269. 155917–155917.
3.
Winge-Main, A., et al.. (2024). Use of Immune Checkpoint Inhibitor (ICI) Therapy for Cutaneous Melanoma from 2014 to 2021 in Norway: Insights from Real-World Data. SHILAP Revista de lepidopterología. 2. 100170–100170.
4.
Ghiasvand, Reza, Bettina Kulle Andreassen, Adèle C. Green, et al.. (2023). Statin use and risk of cutaneous melanoma: a nationwide nested case–control study. British Journal of Dermatology. 188(6). 805–807. 1 indexed citations
5.
Støer, Nathalie C., et al.. (2023). Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study. Breast Cancer Research. 25(1). 101–101. 9 indexed citations
6.
Kristensen, Kasper Bruun, Søren Friis, Lars Christian Lund, et al.. (2022). Identification of Drug–Cancer Associations: A Nationwide Screening Study. Cancer Research Communications. 2(6). 552–560. 2 indexed citations
7.
Ghiasvand, Reza, Bettina Kulle Andreassen, Jo S Stenehjem, et al.. (2022). Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study. International Journal of Epidemiology. 52(3). 887–898. 2 indexed citations
8.
Støer, Nathalie C., et al.. (2022). Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study. BMC Cancer. 22(1). 1301–1301. 4 indexed citations
9.
Andreassen, Bettina Kulle, Jo S Stenehjem, Trond Heir, et al.. (2020). <p>Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study</p>. Clinical Epidemiology. Volume 12. 1389–1401. 11 indexed citations
10.
Stenehjem, Jo S, Ronnie Babigumira, H. Dean Hosgood, et al.. (2020). Cohort Profile: Norwegian Offshore Petroleum Workers (NOPW) Cohort. International Journal of Epidemiology. 50(2). 398–399. 10 indexed citations
11.
Flåm, Siri T., Maria D. Mjaavatten, Siri Lillegraven, et al.. (2020). Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4+ Memory Than in CD4+ Naïve T Cells. Frontiers in Immunology. 11. 194–194. 18 indexed citations
12.
Andreassen, Bettina Kulle, Jo S Stenehjem, Inger Kristin Larsen, et al.. (2019). Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case–control study. BMJ Open. 9(2). e025246–e025246. 6 indexed citations
13.
Andreassen, Bettina Kulle, Nathalie C. Støer, Jan Ivar Martinsen, et al.. (2019). Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study. BMJ Open. 9(4). e028504–e028504. 6 indexed citations
14.
Gislefoss, Randi E., Jo S Stenehjem, Bettina Kulle Andreassen, et al.. (2018). Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study. BMJ Open. 8(3). e019309–e019309. 10 indexed citations
15.
Andreassen, Bettina Kulle, Bjarte Aagnes, Randi E. Gislefoss, Mikkel Andreassen, & Rolf Wahlqvist. (2016). Incidence and Survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014. BMC Cancer. 16(1). 799–799. 30 indexed citations
16.
Gervin, Kristina, Bettina Kulle Andreassen, Hanne Sagsveen Hjorthaug, et al.. (2016). Intra-individual changes in DNA methylation not mediated by cell-type composition are correlated with aging during childhood. Clinical Epigenetics. 8(1). 110–110. 18 indexed citations
17.
Kalla, Rahul, Nicholas A. Kennedy, Fredrik Hjelm, et al.. (2015). P140. Proximity Extension Assay technology identifies novel serum biomarkers for predicting Inflammatory Bowel Disease: IBD Character Consortium. Journal of Crohn s and Colitis. 9(suppl 1). S146–S147. 1 indexed citations
18.
Kalla, Rahul, Nicholas A. Kennedy, Fredrik Hjelm, et al.. (2015). Su1201 Proximity Extension Assay Technology Identifies Novel Serum Biomarkers for Predicting Inflammatory Bowel Disease: IBD Character Consortium. Gastroenterology. 148(4). S–436. 1 indexed citations
19.
Andreassen, Bettina Kulle, et al.. (2014). Altered DNA methylation profile in Norwegian patients with Autoimmune Addison's Disease. Molecular Immunology. 59(2). 208–216. 12 indexed citations
20.
Tesli, Martin, Anna K. Kähler, Bettina Kulle Andreassen, et al.. (2009). No association between DGKH and bipolar disorder in a Scandinavian case–control sample. Psychiatric Genetics. 19(5). 269–272. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Eisenhardt Breakdown of academic impact, for papers by Katarzyna Ziemnicka Breakdown of academic impact, for papers by Craig C. Teerlink Breakdown of academic impact, for papers by Michaela Onstad Breakdown of academic impact, for papers by Claire Briet Breakdown of academic impact, for papers by Meng Huang Breakdown of academic impact, for papers by A. O’Meara Breakdown of academic impact, for papers by Yumiko Okubo Breakdown of academic impact, for papers by Tony Huynh Breakdown of academic impact, for papers by Joon Ho Song
Rankless by CCL
2026